Physiological Signaling and Structure of the HGF Receptor MET
The Hepatocyte Growth Factor (HGF), also known as Scatter Factor, is a multifunctional cytokine crucial for triggering epithelial cell proliferation, movement, and survival. This unique combination of properties induces an essential transition in cells, pivotal for embryonic development and exploited by cancer cells during metastasis. The HGF receptor, MET, a transmembrane tyrosine kinase receptor, plays a central role in coordinating epithelial proliferation, motility, and morphogenesis through HGF-driven physiological signaling.
The HGF gene, located on chromosome 7q21.11, encodes several isoforms, including full-length HGF and splicing variants like NK1 and NK2, each with distinct affinities and potencies in binding to the MET receptor. Post-translational modifications, such as proteolytic cleavage and glycosylation, are essential for the activation and biological activity of HGF. The interaction between HGF and MET initiates a cascade of signaling events, leading to cell motility, proliferation, and tubular morphogenesis.
The MET gene, found on chromosome 7q31, encodes a 1390 amino acid protein that plays a crucial role in various tissues and cell types, predominantly in epithelial-derived cells. Alternative splicing generates multiple variants of MET, each with unique functions. Post-translational modifications, including glycosylation and cleavage, are crucial for the maturation and activation of MET. The tyrosine kinase activity of MET transduces signals initiated by HGF, leading to mitogenic and motogenic responses in cells.
The intricate signaling pathways downstream of MET activation involve a network of key signaling molecules, such as GRB2, GAB1, PI3K, and PLCγ, which regulate processes like cell motility, proliferation, survival, and differentiation. MET signaling also influences various cellular functions like cytoskeletal rearrangement, adhesion dynamics, and transcriptional control. The activation of downstream effectors, such as ERK, AKT, and STAT3, orchestrates the balance between proliferation, apoptosis resistance, and cytoskeletal remodeling in response to HGF stimulation.
The biological effects of MET activation, including epithelial-mesenchymal transition (EMT), tubulogenesis, and cell survival, highlight the versatile nature of HGF-MET signaling in regulating complex cellular processes. From cell scattering to invasive growth programs, MET activation drives a series of cellular responses essential for embryonic development, tissue homeostasis, and cancer progression. Understanding the intricate interplay between HGF and MET provides valuable insights into the molecular mechanisms underlying cell behavior, with implications for therapeutic interventions targeting MET signaling in various diseases.
Key Takeaways:
– HGF-MET signaling is essential for coordinating epithelial cell behaviors like proliferation, motility, and survival.
– Post-translational modifications of HGF and MET are critical for their activation and biological functions.
– MET activation triggers a complex network of downstream signaling pathways that regulate cellular processes like proliferation, apoptosis resistance, and cytoskeletal dynamics.
– The biological effects of MET signaling, including EMT, tubulogenesis, and cell survival, underscore its significance in developmental processes and disease progression.
Tags: secretion, regulatory, mass spectrometry, post-translational modification, downstream
Read more on pmc.ncbi.nlm.nih.gov